The biopharmaceutical industry has experienced incredible exponential growth in recent decades. Annual revenues have increased from US$4.4 billion (£3.4 billion) in 1990 to $275 billion (£213 billion) in 2018 (a… Read More »
Diagnoses of chronic illnesses such as rheumatoid arthritis (RA), Crohn’s disease and osteoporosis are expected to skyrocket in the coming decade, resulting in growing use of patient-centric drug delivery devices… Read More »
Overall rates of chronic illnesses such as diabetes, multiple schlerosis (MS) and rheumatoid arthritis (RA) are expected to skyrocket in the coming years. Treating these diseases successfully—and managing their associated… Read More »
At the just-concluded PDA Universe of Pre-Filled Syringes meeting (Orlando, FL, Oct. 8-9), Noble, an Orlando, FL, manufacturer, demo’d a new training platform for patients using prefilled syringes based on… Read More »
In this article, Joe Reynolds, Research Manager at Noble, using Noble’s collaboration with BD as an example, discusses the value of demonstrators for making patients comfortable and effective with their… Read More »
The global injectable drug delivery market is growing around 11.8% CAGR and will soon eclipse oral delivery as the most valuable route of administration of pharmaceuticals. The market was valued… Read More »